We are live on ! Find out more
PAM

Parvin Asset Management Portfolio holdings

AUM $139M
1-Year Est. Return 49.07%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+49.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$11.3M
Cap. Flow
+$6.07M
Cap. Flow %
4.82%
Top 10 Hldgs %
25.74%
Holding
345
New
58
Increased
52
Reduced
110
Closed
35

Top Buys

Rank Stock Value
1
CLX icon
Clorox
CLX
+$1.34M
2
EOG icon
EOG Resources
EOG
+$1.16M
3
RYN icon
Rayonier
RYN
+$929K
4
GNTX icon
Gentex
GNTX
+$830K
5
OTEX icon
Open Text
OTEX
+$815K

Top Sells

Rank Stock Value
1
GPC icon
Genuine Parts
GPC
+$1.06M
2
ORCL icon
Oracle
ORCL
+$738K
3
CSCO icon
Cisco
CSCO
+$692K
4
HL icon
Hecla Mining
HL
+$601K
5
OR icon
OR Royalties Inc
OR
+$522K

Sector Composition

Rank Sector Weight
1 Materials 33.14%
2 Technology 13.75%
3 Consumer Staples 11.66%
4 Industrials 9.88%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIV icon
176
Telefônica Brasil
VIV
$19.4B
$80.4K 0.06%
6,775
OKE icon
177
Oneok
OKE
$53.8B
$79.8K 0.06%
1,086
-51
-4% -$3.61K
FDX icon
178
FedEx
FDX
$73.2B
$79.4K 0.06%
275
-550
-67% -$144K
SPIR icon
179
Spire Global
SPIR
$500M
$78.9K 0.06%
+10,525
New +$103K
DEA
180
Easterly Government Properties
DEA
$1.15B
$77.3K 0.06%
3,650
-160
-4% -$3.47K
DFAS icon
181
Dimensional US Small Cap ETF
DFAS
$15.8B
$76.6K 0.06%
1,100
PAYX icon
182
Paychex
PAYX
$41.8B
$75.2K 0.06%
670
IUS icon
183
Invesco RAFI Strategic US ETF
IUS
$946M
$74.6K 0.06%
1,305
NVS icon
184
Novartis
NVS
$294B
$72.4K 0.06%
525
EL icon
185
Estee Lauder
EL
$31.7B
$70.7K 0.06%
675
-225
-25% -$21.8K
FNDF icon
186
Schwab Fundamental International Large Company Index ETF
FNDF
$25.3B
$70.4K 0.06%
1,557
D icon
187
Dominion Energy
D
$59.8B
$70.3K 0.06%
1,200
DLO icon
188
dLocal
DLO
$4.52B
$69.3K 0.06%
4,900
KOF icon
189
Coca-Cola Femsa
KOF
$23.1B
$68.7K 0.05%
725
IRM icon
190
Iron Mountain
IRM
$36.2B
$68K 0.05%
820
-12
-1% -$1.12K
PCH
191
DELISTED
PotlatchDeltic
PCH
$67.6K 0.05%
1,700
-6,195
-78% -$251K
TKR icon
192
Timken Company
TKR
$9.18B
$66.5K 0.05%
790
-30
-4% -$2.39K
HXL icon
193
Hexcel
HXL
$7.86B
$65.8K 0.05%
890
STLD icon
194
Steel Dynamics
STLD
$38.3B
$64.4K 0.05%
380
-1,245
-77% -$198K
CAG icon
195
Conagra Brands
CAG
$7.23B
$64.3K 0.05%
3,715
-1,530
-29% -$27.2K
AMT icon
196
American Tower
AMT
$76.2B
$63.2K 0.05%
360
-657
-65% -$120K
IWP icon
197
iShares Russell Mid-Cap Growth ETF
IWP
$20.5B
$60.9K 0.05%
+445
New +$62.2K
MDY icon
198
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$60.3K 0.05%
100
EVT icon
199
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.15B
$59.2K 0.05%
2,350
BALL icon
200
Ball Corp
BALL
$16.9B
$58.3K 0.05%
1,100

Similar funds

Parvin Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Parvin Asset Management held 345 positions worth $126M, up 9.9% from $115M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Parvin Asset Management deployed $6.07M of net new capital in Q4 2025, opening 58 new positions and adding to 52 existing holdings. Its largest new stake was Rayonier: 41,075 shares worth $889K.

By sector, the portfolio is most concentrated in Materials at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Genuine Parts, an estimated $1.06M trimmed.

  • Parvin Asset Management's largest Q4 2025 buy was Rayonier: 41,075 shares worth $889K.
  • Parvin Asset Management added most to Clorox in Q4 2025, an estimated $1.34M increase.
  • Parvin Asset Management's biggest Q4 2025 reduction was Genuine Parts, cutting an estimated $1.06M.
  • Parvin Asset Management fully exited GeoPark in Q4 2025, selling an estimated $408K.
  • Parvin Asset Management's ten largest holdings make up 26% of its $126M portfolio in Q4 2025.
  • Parvin Asset Management opened 58 new positions and closed 35 in Q4 2025.
  • Parvin Asset Management's portfolio value rose 9.9% quarter-over-quarter to $126M.

Based on Parvin Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.